Letter by Azzalini and Stone Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial"

Lorenzo Azzalini; Gregg W. Stone

doi:10.1161/CIRCINTERVENTIONS.120.009140

Letter by Azzalini and Stone Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial"

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E009140
Journal	Circulation: Cardiovascular Interventions
Volume	13
Issue number	4
DOIs	https://doi.org/10.1161/CIRCINTERVENTIONS.120.009140
State	Published - 1 Apr 2020

Access to Document

10.1161/CIRCINTERVENTIONS.120.009140

Cite this

@article{63600e0dbc3e46a5accb663cbfbae3bb,

title = "Letter by Azzalini and Stone Regarding Article, {"}Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial{"}",

author = "Lorenzo Azzalini and Stone, {Gregg W.}",

note = "Funding Information: Dr Azzalini received honoraria from Abbott Vascular, Guerbet, Terumo, and Sahajanand Medical Technologies and research support from ACIST Medical Systems, Guerbet, and Terumo. Dr Stone received speaker or other honoraria from Cook, Terumo, Qool Therapeutics, and Orchestra Biomed; served as a consultant to Valfix, TherOx, Vascular Dynamics, Robocath, HeartFlow, Gore, Ablative Solutions, Miracor, Neovasc, V-Wave, Abiomed, Ancora, MAIA Pharmaceuticals, Vectorious, Reva, and Matrizyme; and received equity/options from Ancora, Qool Therapeutics, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, MedFocus family of funds, and Valfix.",

year = "2020",

month = apr,

day = "1",

doi = "10.1161/CIRCINTERVENTIONS.120.009140",

language = "English",

volume = "13",

pages = "E009140",

journal = "Circulation: Cardiovascular Interventions",

issn = "1941-7640",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "4",

}

Letter by Azzalini and Stone Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial". / Azzalini, Lorenzo; Stone, Gregg W.
In: Circulation: Cardiovascular Interventions, Vol. 13, No. 4, 01.04.2020, p. E009140.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Letter by Azzalini and Stone Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention

T2 - Insights From DIVA Trial"

AU - Azzalini, Lorenzo

AU - Stone, Gregg W.

N1 - Funding Information: Dr Azzalini received honoraria from Abbott Vascular, Guerbet, Terumo, and Sahajanand Medical Technologies and research support from ACIST Medical Systems, Guerbet, and Terumo. Dr Stone received speaker or other honoraria from Cook, Terumo, Qool Therapeutics, and Orchestra Biomed; served as a consultant to Valfix, TherOx, Vascular Dynamics, Robocath, HeartFlow, Gore, Ablative Solutions, Miracor, Neovasc, V-Wave, Abiomed, Ancora, MAIA Pharmaceuticals, Vectorious, Reva, and Matrizyme; and received equity/options from Ancora, Qool Therapeutics, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, MedFocus family of funds, and Valfix.

PY - 2020/4/1

Y1 - 2020/4/1

UR - http://www.scopus.com/inward/record.url?scp=85083208574&partnerID=8YFLogxK

U2 - 10.1161/CIRCINTERVENTIONS.120.009140

DO - 10.1161/CIRCINTERVENTIONS.120.009140

M3 - Letter

C2 - 32279565

AN - SCOPUS:85083208574

SN - 1941-7640

VL - 13

SP - E009140

JO - Circulation: Cardiovascular Interventions

JF - Circulation: Cardiovascular Interventions

IS - 4

ER -